BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8677897)

  • 1. Prognosis of patients with stable angina pectoris on antianginal drug therapy.
    Hjemdahl P; Eriksson SV; Held C; Rehnqvist N
    Am J Cardiol; 1996 Jun; 77(16):6D-15D. PubMed ID: 8677897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
    Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
    Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
    Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
    Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
    Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
    Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
    Dargie HJ; Ford I; Fox KM
    Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
    Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
    Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.
    Crake T; Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Heart J; 1987 Dec; 58(6):617-20. PubMed ID: 3322352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
    Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
    Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
    Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and calcium antagonists in angina pectoris. The potential role of combination therapy.
    Dargie HJ
    Drugs; 1988; 35 Suppl 4():44-50. PubMed ID: 2897903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group.
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):379-86. PubMed ID: 1520648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
    Voronkov LG; Lysenko AF
    Kardiologiia; 1992; 32(11-12):67-70. PubMed ID: 1297887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
    Akhras F; Jackson G
    Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
    Wallace WA; Wellington KL; Chess MA; Liang CS
    Am J Cardiol; 1994 Jan; 73(1):23-8. PubMed ID: 8279372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.